QIAGEN Launches QIAprep&amp Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts

About this update from Qiagen N.v.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":242,"height":204,"url":"https://media.zenfs.com/en/business-wire.com/bd7f7dc280ce296c1bad1520c28e4f06"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3E5x5_tBTkLcaolD8TG23w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM1NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/bd7f7dc280ce296c1bad1520c28e4f06","width":242,"height":204}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 – over 90% of them in Africa","length":134,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"QIAprep&amp Plasmodium Kit enables streamlined detection of five malaria-causing parasites for epidemiological research and surveillance","length":140,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Novel QIAGEN assays support mixed-infection tracking, vaccine impact assessment and malaria control strategies in regions with limited healthcare infrastructure","length":160,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":434,"olType":false},{"type":"text","content":"VENLO, Netherlands, April 01, 2025--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAprep&amp Plasmodium Kit and two companion assays to support malaria research and surveillance efforts.","length":252,"tagName":"p"},{"type":"text","content":"This new solution combines sample preparation and quantitative PCR (qPCR) into a single workflow, providing a rapid and accessible tool for detecting malaria-causing parasites from blood samples.","length":195,"tagName":"p"},{"type":"text","content":"Malaria remains one of the world’s most pressing public health challenges, particularly in tropical and subtropical regions. The disease is caused by five species of Plasmodium parasites, with Plasmodium falciparum responsible for the most severe cases. In 2024 alone, malaria accounted for more than 250 million cases worldwide, with over 90% occurring in Africa.","length":364,"tagName":"p"},{"type":"text","content":"While the integration of vaccines into anti-malaria programs began in 2024, and mark a significant milestone, comprehensive m...

More updates from Qiagen N.v.